CPH EXAM Definitions

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/498

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

499 Terms

1
New cards

Attributable risk

Rate of disease in exposed individuals that can be attributed to the exposure. Or the proportion of all cases that can be attributed to a particular exposure.

2
New cards

Adjusted rate

Effects of differences in composition of pops being compared have been minimized by statistical methods.

ex: regression analysis and strandardization

-often used on rates or relative risks

3
New cards

Ecological Fallacy

Bias that may occur because an association observed between variables or an aggregate level does not represent the association that exists at an individual level

4
New cards

Confidence Interval

95% confident that the true value of a variable is contained within the interval.

-used to account for sampling variability

-it is a point estimate +_ margin of error, where the point estimate is the best estimate of teh unknown parameter and the margin of error is the product of the confidence level and the standard error.

if a 95% CI for the differences in mean does not include 0 (the null value) then there is eveidence of a statistically significant difference at sigma=0.05

5
New cards

Clinical Trial Phases

1. Safety and Pharmacologic profiles

2. pilot efficacy studies

3. extensive clinical trials

4. after the FDA approves, look at specific effects to establish incidence of adverse reactions, etc. longterm use effects.

6
New cards

interpretation of studies

temporality: cause precedes effect

Specificity: important in assessing the possibility of biases.

Consistency: several studies showing similar results. homogeneity statistically.

7
New cards

Confounders

-non-causal association between exposure and outcome as a result of a third variable.

-distortion of effect by other factors

-must be related to exposure AND outcome

-not an intermediate variable on causal pathway

8
New cards

Controlling for confounders

before data collection: random collection, individual matching, frequency matching

After data collection: direct adjustment, indirect adjustment, mantel-haenszel, regression techniques

9
New cards

Quality Assurance vs. Quality Control

QA: ensure quality before data collection

QC: monitor and maintain quality during study

10
New cards

reliability vs. validity

R: precision, reproducibility

V: accuracy, absence of bias

11
New cards

systematic error

(lack of validity) if there's a difference between what is actually being estimated and what is intended to be measured. Increasing sample size doesn't help.

12
New cards

Random Error

(lack of precision) occurs, but increasing sample size helps.

13
New cards

RCT studies

Tests efficacy or effectiveness of healthcare services. random allocation of participants to different treatments. Includes blinding, placebo. gold standard for evidence.

14
New cards

Community Intervention/cluster RCT

community-wide basis or groupwide

15
New cards

Case-Crossover RCT design

-cases serve as their own control

-exposure has transient effect

16
New cards

Cross Sectional Studies

SNAPSHOT! at a single point in time. tells the prevalence and association. causation cannot be implied. a study that examines the relationship between diseases and other variables as they exist in a defined population at one particular time.

17
New cards

Matching

used to make cases and controls as similar as possible to avoid confounding. ex: race, gender, age. +Maybe the only way to control confounding. increases statistical power, straightforward. -requires use of special analytical techniques, residual confounding can occur if you match continuous variables by category.

18
New cards

types of matching

individual matching: case and control matched individually

frequency matching: a group of controls

Minimum Euclidean Distance measure: match to closest person.

19
New cards

Cohort Studies

RISK RATIO, RELATIVE RISK, INCIDENCE RATE, RATE RATIO

-rare exposures

-group of subjects who shared experiences during a particular time. Determines if incidence is related to exposure.

20
New cards

Concurrent/longitudinal cohort studies

starts now (with a baseline exam) and goes into future. expensive and time intensive.

21
New cards

non-concurrent/retrospective cohort studies

assembled in past based on existing records. faster and quicker, but records can be limited or biased. follow up can be hard.

22
New cards

Prevalence of disease

measure of the burden of disease in a community (new and existing cases). the number of events in a given population at a designated time.

-obscures causal relationships

23
New cards

point prevalence

-proportion of pop that is diseased during a single point of time.

-at a specific point in time

number of cases at a particular moment/

number in population at that moment

24
New cards

period prevalence

-proportion of pop that is diseased during a specified duration of time.

-during a specific period of time

number of cases during a specified time period/

number in population at midpoint of period

25
New cards

incidence of disease

measure of risk (new cases)

the rate at which people without a disease develop the disease during a specific period of time.

#of new cases over a period of time/

population @ risk of the disease in that time

26
New cards

incidence rate (also incidence density)

CASES OF DISEASE/PERSON-TIME AT RISK

TIME is important.

-it shows greater accuracy, but is hard to calculate.

-used for causal research

27
New cards

Incidence Proportion

CASES OF DISEASE/PERSONS AT RISK

cumulative risk/average risk

the proportion of a group of people who experience the onset of a health-related event during a specified time interval.

28
New cards

Incidence Odds

CASES OF DISEASE/SURVIVORS

Ratio of people who experience outcome to ratio of people who no not experience outcome.

29
New cards

Rate Ratio

ratio of incidence rate in the exposed group to the non-exposed group

30
New cards

Risk Ratio

-measures the increased risk for developing a disease after being exposed to a risk factor compared to not being exposed to the risk factor.

RR= risk for the exposed/

risk for the unexposed

-often referred to as "relative risk"

31
New cards

Odds Ratio

Ratio of incidence odds in exposed group to non-exposed group.

[p1/(1/p1)]/[p2/(1/p2)]

OR: ad/bc

exposed not exposed

cases a b

controls c d

32
New cards

Information Bias (also observational bias)

systematic error/flaw due to incorrect definition, measurement, or classification that results in reduced quality (accuracy)

Ex: false positives/negatives or errors in death records.

33
New cards

Differential Information Bias

Probability of cases vs. non-cases of misclassification is different.

34
New cards

Non-Differential Information Bias

Probability of cases vs. non-cases of misclassification is NOT different.

35
New cards

Selection Bias

When sample/participants aren't representative. how to avoid: control confounders and choose good comparison group.

36
New cards

power

-the ability to reject the null hypothesis when the null is in fact false.

-probability of detecting a difference if one truly exists. 1-beta= probability of declaring a difference not statistically significant when a difference truly exists.

37
New cards

Type 1 Error

reject the null hypothesis when it is true

alpha or

<p>reject the null hypothesis when it is true</p><p>alpha or</p>
38
New cards

Type 11 Error

fail to reject the null hypothesis when it is false

beta

<p>fail to reject the null hypothesis when it is false</p><p>beta</p>
39
New cards

aggregate data

vital stats, data from govt databases, summaries from reporting systems, production and sales data, group-level. COMBINED

40
New cards

individual level data

questionnaires, medical records, national surveys, biological specimens

41
New cards

Stages of disease prevention

Primary, secondary, tertiary

42
New cards

Primary Disease Prevention

Prevent it from occurring (vaccines)

43
New cards

Secondary Disease Prevention

Modify severity (better access to ER)

44
New cards

Tertiary Disease Prevention

Rehabilitation. measures to prevent reoccurrence of disease

45
New cards

Rate of Disease

how fast is the disease occurring in the population

46
New cards

Proportion of Disease

What fraction of the population is affected?

47
New cards

Case Fatality (CF) or Fatality Rate

Measures of the severity of disease.

9 deaths per 10,000/1 year

Within a given year, out of 10,000 people diagnosed with a disease, 9 died.

48
New cards

Secondary Attack Rate (person-to-person spread)

# of persons sick by the primary case/# exposed to primary case

49
New cards

Attack Rate

# of people at risk who develop disease /# of people at risk

50
New cards

Outbreak investigation steps

1. define epidemic

2. look for the time-place interaction of cases

3. look for combination of variables

4. Develop hypothesis

5. Recommend control measures

51
New cards

Common Source Outbreaks

groups of persons exposed to common agent

52
New cards

Propagated Outbreaks

spreads gradually from person to person

53
New cards

Mixed epidemic Outbreaks

both common source and person to person exposure

54
New cards

Persistent Organic Pollutants (POPs)

toxic chemicals that persist in the environment for long periods of time. adverse effects on humans and animals. circulates globally.

55
New cards

organophosphates

pesticides that contain phosphorus. short lived. toxic when first applied.

56
New cards

Mutagen

agent that causes a permanent genetic change outside of normal growth.

57
New cards

mutagenicity

capacity to cause permanent genetic change

58
New cards

MRSA

bacterial strains. resistent to antibiotics. benign colonizers of the skin. may cause severe infections.

59
New cards

Morbidity

rate of disease, incidence. HOW MANY PEOPLE ARE SICK

60
New cards

Mortality

death rate. PEOPLE WHO HAVE DIED.

61
New cards

Metabolism

conversion or breakdown of a substance from one form to another by a living organism

62
New cards

metabolites

substance produced by biological processes

63
New cards

metabolomics

use of genomic information to facilitate studies of metabolic processes.

64
New cards

Latency

time from 1st exposure until the appearence of a toxic effect.

65
New cards

IRIS (integrated risk information system)

descriptive, quantitative regulatory information on chemicals. health professionals not experts.

66
New cards

Incidence

# of new cases in a defined population over a specific time period.

67
New cards

hydrophilic

strong affinity for water

68
New cards

hydrophobic

strong aversion for water

69
New cards

helminths

group of parasites that infect humans (Schistosoma haematobium) cestodes: beef and pork tapeworms

70
New cards

HACCP (hazard analysis and critical control points)

production control system for the food industry. identifies potential contamination and then strictly manages and monitors points. designed to prevent rather than catch.

71
New cards

gray (Gy)

international system unit of absorbed dose

72
New cards

exposure-dose reconstruction

method of estimating the amount of past exposures to hazardous substances. computers and approximation methods can be used when info is missing or limited.

73
New cards

EPCRA (emergency planning and community right-to-know act)

requirements for federal, stat and local govts regarding emergency planning and CRTK reporting on hazardous and toxic chemicals.

-triggered by Bhopal, India 2,000 people died by release of methyl isocyanate.

74
New cards

ED50

dose of drug that is pharmacologically effective for 50% of the population.

75
New cards

disease vector

intermediate host for parasites. required for development. delivers parasite to subsequent hosts.

ex: schistosoma

76
New cards

Curie

basic unit to describe the intensity of radioactivity in a sample of material.

77
New cards

cryptosporidium

microbe that is transmitted through water and person-to-person contact. causes acute diarrhea, stomach pain, vomiting, fever.

-milwaukee episode, largest waterborne disease outbreak.

78
New cards

Criteria Pollutants

1970 ammendment to Clean Air Act. required EPA to set standards for 6 pollutants.

ozone, carbon monoxide, total suspended particles, sulfurdioxide, lead, nitrogenoxide.

79
New cards

Comparison value

the calculated concentration of a substance in air, food, or soil that is unlikely to cause harm. used as a screening level during assessment process.

80
New cards

Command and Control

regulates how activities need to be carried out. compliance monitoring and sanctions of trespasses. CONS: inflexibility, not adaptable, no incentive for reaching higher.

81
New cards

CBRNE incidents

deliberate malicious acts with the intention of killing others and disrupting society.

CHEMICAL, BIOLOGICAL, RADIOACTIVE, NUCLEAR, EXPLOSIVE.

82
New cards

Temporality

The cause must precede the effect

83
New cards

Specificity

-the proportion of truly nondiseased persons who are so identified by the screening test.

-Specificity of the effect is important in assessing possibility of biases

true negatives/disease free population

D/B+D

"of those who do not have disease, __% will test negative."

84
New cards

Interaction

This occurs when the incidence of disease in the presence of two or more risk factors differs from the incidence expected to result from their individual effects

85
New cards

Epidemiology's basic ethical principles

1. respect for people

2. Beneficence (do not harm)

3. Justice

86
New cards

Applications of Epidemiology's basic ethical principles

1. informed consent

2. assessment of risk and benefit

3. selection of subjects

87
New cards

Tuskegee Syphilis Experiment

A clinical study conducted between 1932 and 1972 in Tuskegee, Alabama by The U.S. Public Health Service. 399 impoverished African American sharecroppers with syphilis were recruited for research related to the natural progression of the untreated disease. After penicillin was discovered as a cure, researchers continued to deny such treatments to medical participants for another 25 years. Many patients were lied to and given placebo treatments so researchers could observe the progression of the fatal disease. This study led to the 1979 Belmont Report and establishment of the Office for Human Research Protection (OHRP). In 1974, Congress passed the National Research Act and created a commission to study and write regulations governing studies involving human participants.

88
New cards

Accuracy

The degree to which a measurement or an estimate based on measurements represents the true value of the attribute that is being measured.

89
New cards

Acute Disease

a health effect with sudden onset, often brief. sometimes used to mean severe.

90
New cards

adjusted rate

a rate in which the effects of differences in composition of the populations being compared have been minimized by statistical measures.

91
New cards

Association

statistical dependence between two or more events, characteristics or other variables.

92
New cards

attack rate

the cumulative incidence of infection in a group observed over a period during an epidemic.

93
New cards

Crude rate

a summary rate based on the actual number of events in a population over a given time period.

94
New cards

death rate

an estimate of the portion of a population that dies during a specific period.

#of people dying /population

95
New cards

Ecologic study

a study in which the units of analysis are populations or groups of people rather than individuals.

96
New cards

etiology

the science of causes, causality.

97
New cards

Hawthorne Effect

The effect of knowing that you're being studied influences behavior.

98
New cards

healthy worker effect

workers usually exhibit lower overall death rates than the general population because chronically ill are bared from employment.

99
New cards

index case

the first case in a family or other defined group to come to the attention of the investigator

100
New cards

induction period

the period required for a specific cause to produce disease. the interval from the causal action of a factor to the initiation of the disease.